Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07149259 · ClinicalTrials.gov registry record · NA
Assessing the Impact of eSight Go At-Home Usage in Individuals With Visual Impairment
A NA study of Low Vision Aids, sponsored by Brooks Rehabilitation.
- Recruiting
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT07149259 is a NA study of Low Vision Aids that is actively recruiting participants, run by Brooks Rehabilitation. The registered enrollment target is 50 participants. The trial reports 1 study location across 1 state.
The verdict
NCT07149259, a NA study of Low Vision Aids, is actively recruiting participants, sponsored by Brooks Rehabilitation.
- RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
This research aims to test the updated version of Gentex's device, eSight Go, an image enhancing wearable device to assist those with vision impairments limiting activities of daily living.
Conditions Studied
Interventions
- DEVICE At Home Use
Study Locations (1)
Florida
- Brooks Rehabilitation - Jacksonville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2025-06-18 |
| Est. Completion | 2026-06-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07149259
The ClinicalTrials.gov registry entry for NCT07149259 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brooks Rehabilitation, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Low Vision Aids appearing as the primary indexed condition, and to 1 intervention - of which At Home Use is the first listed.
NCT07149259 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT07149259 about?
NCT07149259 is a clinical study titled "Assessing the Impact of eSight Go At-Home Usage in Individuals With Visual Impairment". This research aims to test the updated version of Gentex's device, eSight Go, an image enhancing wearable device to assist those with vision impairments limiting activities of daily living.
What is the current status of trial NCT07149259?
This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2025-06-18. Estimated completion is 2026-06-01.
What conditions does trial NCT07149259 study?
This clinical trial studies the following conditions: Low Vision Aids.
What interventions are being tested in trial NCT07149259?
The interventions under investigation include: At Home Use (DEVICE).
Who is sponsoring clinical trial NCT07149259?
This trial is sponsored by Brooks Rehabilitation, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07149259 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Low Vision Aids
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.